Brooklyn Investment Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,430
Closed -$8.96K 2807
2024
Q4
$8.96K Buy
+5,430
New +$8.96K ﹤0.01% 1019